Application of image-guided adaptive radiation therapy in lung cancer

doi:10.3760/cma.j.issn.1673-422X.2014.12.011

Abstract

Abstract: Corresponding author: Adaptive radiotherapy (ART) is the product of excellence technology. It reschedules, registers according to tumor′s size, shape and alteration of relative position with the surrounding tissue during the treatment. Thereby it raises the accuracy of the conformal radiotherapy. The technology is gradually being chosen by more and more patients. The technology can increase the rate of local control significantly, while reducing the occurrence of radiationrelated adverse reactions.

Key words: Lung neoplasms, Therapeutic uses, Adaptive radiotherapy

FANG Jin-Mei, WANG Fan. Application of image-guided adaptive radiation therapy in lung cancer[J]. Journal of International Oncology, 2014, 41(12): 912-914.

References

［1］奚江, 李文辉, 王丽. 无法手术局部晚期非小细胞肺癌的治疗［J］. 国际肿瘤学杂志, 2014, 41(4): 279282. ［2］ Sonke JJ, Belderbos J. Adaptive radiotherapy for lung cancer［J］. Semin Radiat Oncol, 2010, 20(2): 94106. ［3］ Simone CB 2nd, Ly D, Dan TD, et al. Comparison of intensitymodulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer［J］. Radiother Oncol, 2011, 101(3): 376382. ［4］ Worm ES, Hansen AT, Petersen JB, et al. Inter and intrafractional localisation errors in conebeam CT guided stereotactic radiation therapy of tumours in the liver and Lung［J］. Acta Oncol, 2010, 49(7): 11771183. ［5］ Cole AJ, O′Hare JM, McMahon SJ, et al. Investigating the potential impact of fourdimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy［J］. Clin Oncol (R Coll Radiol), 2014, 26(3): 142150. ［6］ Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in nonsmallcell lung cancer for threedimensional conformal radiotherapy planning［J］. Int J Radiat Oncol Biol Phys, 2000, 48: 10151024. ［7］ Osti MF, Agolli L, Valeriani M, et al. Image guided hypofractionated 3dimensional radiation therapy in patients with inoperable advancedstage nonsmall cell lung cancer［J］. Int J Radiat Oncol Biol Phys, 2013, 85(3): 157163. ［8］王艳阳, 傅小龙, 夏冰. 不同标记点对肺癌图像引导放疗图像配准结果的影响［J］. 中华放射肿瘤学杂志, 2010, 19(6): 517519. ［9］ Lavoie C, Higgins J, Bissonnette JP, et al. Volumetric image guidance using carina vs spine as registration landmarks for conventionally fractionated lung radiotherapy［J］. Int J Radiat Oncol Biol Phys, 2012, 84(5): 10861092. ［10］马长升, 卢洁, 刘同海. 变形配准与经验计算剂量累加法用于肺癌放疗计划累加剂量计算的研究［J］. 中华放射医学与防护杂志, 2012, 32(1): 7073. ［11］ Lim G, Bezjak A, Higgins J, et al. Tumor regression and positional changes in nonsmall cell lung cancer during radical radiotherapy［J］. J Thorac Oncol, 2011, 6(3): 531536. ［12］ Tucker SL, Jin H, Wei X, et al. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with nonsmall cell lung cancer［J］. Int J Radiat Oncol Biol Phys, 2010, 77(3): 691698. ［13］王谨, 庄婷婷, 何智纯, 等. 非小细胞肺癌同期放化疗后重度急性放射性肺炎的预测因素［J］. 中华放射肿瘤学杂志, 2012, 21(4): 326329. ［14］ Zhang ZC, Xu J, Li BS, et al. Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3dimensional conformal radiotherapy for nonsmallcell lung Cancer［J］. Am J Clin Oncol, 2010, 33(3): 271275. ［15］何洪涛, 王军, 刘青, 等. 急性放射性心肌损伤体积剂量因素分析［J］. 中华肿瘤防治杂志, 2014, 21(10): 767770. ［16］侯勇, 尹勇, 王鹏程, 等. 基于KVCBCT形变配准的肺癌自适应计划与静态3DCRT 计划的比较研究［J］. 中华放射肿瘤学杂志, 2012, 21(3): 267270. ［17］ Fox J, Ford E, Redmond K, et al. Quantification of tumor volume changes during radiotherapy for nonsmall cell lung cancer［J］. Int J Radiat Oncol Biol Phys, 2009, 74(2): 341348. ［18］ Kataria T, Gupta D, Bisht SS, et al. Adaptive radiotherapy in lung cancer: dosimetric benefits and clinical outcome［J］. Br J Radiol, 2014, 87(1038): 20130643. ［19］ Gomez DR, Chang JY. Adaptive radiation for lung cancer［J］. J Oncol, 2011, 2011. ［20］ Lavrenkov K, Singh S, Christian JA, et al. Effective avoidance of a functional spectperfused lung using intensity modulated radiotherapy (IMRT) for nonsmall cell lung cancer (NSCLC): an update of planning study［J］. Radiother Oncol, 2009, 91(3): 349352.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	He Jiahui, Hu Qinyong. Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data [J]. Journal of International Oncology, 2024, 51(1): 29-36.
[3]	Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng. Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection [J]. Journal of International Oncology, 2023, 50(12): 711-716.
[4]	Chen Yu, Xu Hua, Liu Hai, Chen Shixin. Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging [J]. Journal of International Oncology, 2023, 50(11): 655-660.
[5]	Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun. Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model [J]. Journal of International Oncology, 2022, 49(9): 532-536.
[6]	Chen Huangjing, Zhu Pengfei, Zhang Qing, Chen Guifang, Yang Chunlin, He Ying. Comparative study on the clinical value of contrast-enhanced ultrasound- and CT-guided percutaneous puncture biopsy in peripheral lung masses [J]. Journal of International Oncology, 2022, 49(8): 459-463.
[7]	Cai Gangxiang, Li Jing, Xu Bin. Advances in neoadjuvant immunotherapy for lung cancer [J]. Journal of International Oncology, 2022, 49(6): 366-370.
[8]	Zhang Jingxian, Yi Dan, Li Xiaojiang. Application of antibody-drug conjugates in the treatment of non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(5): 296-301.
[9]	Gao Min, Feng Jing, Wang Li, Zhong Hai, Wen Yuting, Wan Bing, Zhang Xiuwei. Application of microbiota in the early diagnosis and adjunctive treatment of lung cancer [J]. Journal of International Oncology, 2022, 49(4): 247-251.
[10]	Gao Shile, Lu Donghui, Liu Meiqin, Xu Xingjun, Ma Huan, Zhang Yu. Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(3): 140-145.
[11]	Xie Hongxia, Zuo Jinhui, Liao Dongying, Deng Renfen, Yao Yang, Jia Yingjie, Li Xiaojiang, Kong Fanming. Application of PD-L1 inhibitors in the treatment of non-small cell lung cancer [J]. Journal of International Oncology, 2022, 49(2): 111-115.
[12]	Huang Huayu, Song Qibin, Gong Hongyun, Song Jia. Analysis on the incidence and risk factors of pneumonia in patients with lung cancer receiving thoracic radiotherapy and immunotherapy [J]. Journal of International Oncology, 2022, 49(12): 718-723.
[13]	Zhang Hongjiao, Jiang Jie, Huang Wei. Research progress of functional imaging-assisted radiotherapy target delineation of lung cancer with atelectasis [J]. Journal of International Oncology, 2022, 49(1): 51-55.
[14]	Hu Ge, Su Jie, Li Qiangwei, Xu Peng, Xu Xiuli, Qian Xiaotao. Value of CD4/CD8 ratio and total B lymphocytes before radiotherapy in predicting radiation pneumonitis in patients with esophageal cancer and lung cancer [J]. Journal of International Oncology, 2021, 48(9): 523-526.
[15]	Wang Jun, Zhao Xia, Li Haifei, Zhang Cheng. Clinic diagnostic value of MSCT imaging features in nodular lung adenocarcinoma subtype [J]. Journal of International Oncology, 2021, 48(9): 537-543.